Results 31 to 40 of about 1,733 (155)

UBC9 coordinates inflammation affecting development of bladder cancer [PDF]

open access: yesScientific Reports, 2020
AbstractDysregulation of SUMO modification is linked to carcinogenesis. UBC9 is the sole conjugating enzyme in sumoylation and plays a pivotal role in maintaining homeostasis and restraining stress reactions. However, the clinical significance and function of UBC9 in bladder cancer remain unclear.
Huang, Xiaoliang   +9 more
openaire   +2 more sources

Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation

open access: yesCell Death and Disease, 2023
SUMOylation is an evolutionary conserved regulatory mechanism, in which Ubc9 is the only E2 conjugating enzyme. Previous studies demonstrated that SUMOylation is involved in multiple biological processes, but its role in dendritic cells (DCs) remains to ...
Jing Zhang   +13 more
doaj   +1 more source

Preferential Interaction of Sentrin with a Ubiquitin-conjugating Enzyme, Ubc9 [PDF]

open access: yesJournal of Biological Chemistry, 1997
Sentrin is a ubiquitin-like molecule that has been shown to interact with the death domains of Fas and tumor necrosis factor receptor 1 (TNFR1), PML, Rad51, Rad52, and RanGAP1. We have reported previously that sentrin can be conjugated to other proteins in a manner analogous to protein ubiquitination (Kamitani, T., Nguyen, H. P., and Yeh, E. T.
L, Gong   +4 more
openaire   +2 more sources

Regulation Of Nuclear Localization Of The Sole Sumo-Conjugating Enzyme, Ubc9 [PDF]

open access: yes, 2013
The covalent and reversible conjugation of small ubiquitin-like modifier (SUMO) proteins to hundreds of different cellular proteins is catalyzed by a cascade of enzymes including an E1-activating enzyme (SAE1/SAE2), an E2-conjugating enzyme (Ubc9) and ...
Sekhri, Palak
core   +1 more source

Ubc9 Mediates SUMO2/3 Modification to Regulate Meiosis in Male Mice

open access: yesBiomedicines
Objective: SUMOylation is a crucial protein modification that regulates various physiological and pathological processes. Ubc9 serves as a key ubiquitin-conjugating enzyme in the process of SUMOylation.
Peng Lv   +6 more
doaj   +1 more source

Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae

open access: yes, 2013
Posttranslational modification with the small ubiquitin-related modifier SUMO depends on the sequential activities of E1, E2, and E3 enzymes. While regulation by E3 ligases and SUMO proteases is well understood, current knowledge of E2 regulation is very
Pichler, A.   +13 more
core   +1 more source

Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9 [PDF]

open access: yes, 2011
Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1), the principal viral oncoprotein and a member of the tumor necrosis factor receptor superfamily, is a constitutively active membrane signaling protein that regulates multiple signal transduction ...
Bentz, G. L.   +5 more
core   +1 more source

SUMO and SUMO-Conjugating Enzyme E2 UBC9 Are Involved in White Spot Syndrome Virus Infection in Fenneropenaeus chinensis. [PDF]

open access: yesPLoS ONE, 2016
In previous work, small ubiquitin-like modifier (SUMO) in hemocytes of Chinese shrimp Fenneropenaeus chinensis was found to be up-regulated post-white spot syndrome virus (WSSV) infection using proteomic approach.
Xiaoqian Tang   +4 more
doaj   +1 more source

MicroRNA-mediated Regulation of Ubc9 Expression in Cancer Cells [PDF]

open access: yesClinical Cancer Research, 2009
Abstract Purpose: As an E2-conjugating enzyme for sumoylation, Ubc9 plays a critical role in sumoylation-mediated cellular pathways, ultimately impacting cell growth and cancer development. The aim of this study was to investigate the regulation of Ubc9 in cancer cells. Experimental Design: Immunohistochemistry and Western
Fangting, Wu   +4 more
openaire   +2 more sources

UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer

open access: yesThe Journal of Clinical Investigation, 2023
The role of tumor-associated macrophages (TAMs), along with the regulatory mechanisms underlying distinct macrophage activation states, remains poorly understood in prostate cancer (PCa). Herein, we report that PCa growth in mice with macrophage-specific
Jun Xiao   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy